✦ LIBER ✦

Maintenance treatment of multiple myeloma

✍ Scribed by Michele Baccarani; Renato Fanin; Gianpiero Fasola; Cristiana Gallizia

Book ID: 114791228
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 465 KB
Volume: 43
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.1989.tb01508.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Maintenance treatment of multiple myelom

Maintenance treatment of multiple myeloma with alpha interferon versus an alternating schedule of alpha interferon and chemotherapy

✍ Alice Maniatis 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 201 KB

Randomized trial of α-interferon or dexa

Randomized trial of α-interferon or dexamethasone as maintenance treatment for multiple myeloma

✍ Raymond Alexanian; Donna Weber; Meletios Dimopoulos; Kay Delasalle; Terry L. Smi 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 1 views

A comparison of polychemotherapy and mel

A comparison of polychemotherapy and melphalan/prednisone for primary remission induction, and interferon-alpha for maintenance treatment, in multiple myeloma. A prospective trial of the German Myeloma Treatment Group

✍ D. Peest; H. Deicher; R. Coldewey; R. Leo; R. Bartl; H. Bartels; H.J. Braun; W. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 704 KB

Bortezomib Induction and Maintenance Tre

Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial

✍ Sonneveld, P.; Schmidt-Wolf, I. G. H.; van der Holt, B.; el Jarari, L.; Bertsch, 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 232 KB

176: Phase I/II Trial of Bortezomib Main

176: Phase I/II Trial of Bortezomib Maintenance following Autologous Peripheral Blood Progenitor Cell Transplantation as Treatment for Intermediate- and Advanced-Stage Multiple Myeloma

✍ G.J. Schiller; M. Liao; J.P. Sohn; R. Malone; K. Bartoni; B. Habtemariam; R. Paq 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 48 KB

153: Phase I/II trial of bortezomib main

153: Phase I/II trial of bortezomib maintenance following autologous peripheral blood progenitor cell transplantation as treatment for intermediate- and advanced-stage multiple myeloma

✍ G.J. Schiller; J.P. Sohn; P. Malone; K. Bartoni; B. Habtemariam; P. Paquette; S. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 53 KB